Antibodies for COVID-19
Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of COVID-19, several of which were validated using virus-infected cell lysates.
Explore the collections of COVID-19 Antibodies, Detection Kits.
EPCAM & CD3
State-of-the art technologies helping to deliver guaranteed Fab, scFv, bi-specific, tribodies, humanized antibodies, and more.
Loading...
EPCAM & CD3
This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]
The protein encoded by this gene is part of the T-cell receptor/CD3 complex (TCR/CD3 complex) and is involved in T-cell development and signal transduction. The encoded membrane protein represents the delta subunit of the CD3 complex, and along with four other CD3 subunits, binds either TCR alpha/beta or TCR gamma/delta to form the TCR/CD3 complex on the surface of T-cells. Defects in this gene are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (SCIDBNK). Two transcript variants encoding different isoforms have been found for this gene. Other variants may also exist, but the full-length natures of their transcripts has yet to be defined.
anti-EPCAM immunotoxin MOC31 (IgG)-Bouganin (AGTO-L013O)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Recombinant Anti-EPCAM × Anti-CD3 Bispecific Antibody (Triomab) (TRIO-L023)
-
- Targets: EPCAM & CD3
- Type: Triomab
- Application: FuncS, Promising therapeutic agent
Anti-EPCAM immunotoxin VB4-845 (scFv)-Bouganin (AGTO-G021O)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
anti-EPCAM immunotoxin MOC31 (IgG)-RTA (AGTO-L013R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Anti-EPCAM immunotoxin VB4-845 (scFv)-RTA (AGTO-G021R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Recombinant Anti-EPCAM × Anti-CD3 Bispecific Antibody (TandAb) (TAND-L045)
-
- Targets: EPCAM & CD3
- Type: TandAb
- Application: FuncS, Promising therapeutic agent
Afuco™ Anti-Human EPCAM ADCC Therapeutic Antibody (3622W94), ADCC Enhanced (AFC-223CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: ADCC enhanced antibody
anti-EPCAM immunotoxin MOC31 (IgG)-Gel (AGTO-L013G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Recombinant Anti-EPCAM × Anti-CD3 Bispecific Antibody (F(ab')2) (FAB-L066)
-
- Targets: EPCAM & CD3
- Type: F(ab')2
- Application: FuncS, Promising therapeutic agent
Anti-EPCAM immunotoxin VB4-845 (scFv)-Gel (AGTO-G021G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Recombinant Anti-EPCAM × Anti-CD3 Bi-specific T-cell engagers (BiTE) (BITE-L022)
-
- Targets: EPCAM & CD3
- Type: BitE
- Application: FuncS, Promising therapeutic agent
anti-EPCAM immunotoxin MOC31 (IgG)-DT (AGTO-L013D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Anti-EPCAM immunotoxin VB4-845 (scFv)-DT (AGTO-G021D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Human Anti-Human EPCAM Therapeutic Antibody (3622W94) (TAB-235CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Antibody
- Application: Cyt, FC
Anti-Human CD3 Therapeutic Antibody Fab Fragment (AFM15) (TAB-118CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Fab fragment
anti-EPCAM immunotoxin MOC31 (IgG)-PE (AGTO-L013E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Anti-EPCAM immunotoxin VB4-845 (scFv)-PE (AGTO-G021E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Anti-Human EpCAM Therapeutic Antibody Fab Fragment, 17-1A (Citatuzumab Bogatox) (TAB-112-F(E))
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Fab - G1 - kappa
- Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Anti-Human EPCAM Therapeutic Antibody (Adecatumumab) (TAB-106)
-
- Derivation: Human
- Species Reactivity: Human
- Type: IgG1
- Application: FC, IHC, FuncS, Inhib, Cyt
Anti-EpCAM Therapeutic Antibody (Oportuzumab Monatox) (TAB-774)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: scFv - kappa - heavy
- Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Recombinant Anti-Human EPCAM Antibody scFv Fragment (MOB-1093z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: WB, IHC, FuncS
Recombinant Anti-Human EPCAM Antibody Fab Fragment (MOB-1093z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: RIA, IF, FuncS
Anti-Human EPCAM Therapeutic Antibody (Tucotuzumab Celmoleukin) (TAB-213)
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: WB, Neut, ELISA, IF, IP, FuncS, FC
Anti-Human EpCAM/17-1A Therapeutic Antibody (Edrecolomab) (TAB-701)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: IgG2a - kappa
- Application: ELISA, IP, FC, FuncS, IF, Neut
Anti-Human EpCAM Therapeutic Antibody (Solitomab) (TAB-889)
-
- Derivation: Humanized (from mouse) Bispecific
- Species Reactivity: Human
- Type: (scFv - kappa - heavy) - (scFv - heavy - kappa)
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Recombinant Anti-Human EPCAM Antibody (MOB-1093z)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: IgG
- Application: WB, IHC, FuncS
Rat Anti-CD3 Recombinant Antibody (clone 17A2) (CBMAB-0202MC)
-
- Species Reactivity: Mouse
- Type: Rat IgG2b, κ
- Application: FC, IHC, IP, Activ, CMCD, Depletion
Anti-Mouse CD3 Therapeutic Antibody (Dow2) (TAB-0365CL)
-
- Application: FC, IHC
Anti-Human CD3 Therapeutic Antibody (OKT3) (TAB-0416CL)
-
- Application: FC, IB, ELISA
Recombinant Anti-EpCAM× Anti-CD3 Bi-specific T-cell engagers (BiTE, Adecatumumab) (BSAB-L001)
-
- Targets: EpCAM & CD3
- Type: BiTE
Anti-Human EPCAM Therapeutic Antibody (HE2) (TAB-0531CL)
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Chimeric Anti-Human CD3 Therapeutic Antibody (TAB-0417CL)
-
- Type: Chimeric (mouse/human)
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Recombinant Anti-EpCAM × Anti-CD3 Bi-specific T-cell engagers (BiTE, Solitomab) (BSAB-L006)
-
- Targets: EpCAM & CD3
- Type: BiTE
Humanized Anti-Human CD3 Therapeutic Antibody (TAB-0418CL)
-
- Type: Humanized Antibody
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Human Anti-Human CD3 Therapeutic Antibody (TAB-0532CL)
-
- Type: Human antibody
Anti-Human EPCAM Therapeutic Antibody scFv Fragment (HE2) (TAB-0531CL-S(P))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Mouse Anti-Human CD3 Therapeutic Antibody (TAB-0422CL)
-
- Species Reactivity: cyno CD3ε
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-Mouse CD3 Therapeutic Antibody scFv Fragment (Dow2) (TAB-0365CL-S(P))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-Mouse CD3 Therapeutic Antibody Fab Fragment (Dow2) (TAB-0365CL-F(E))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-Human CD3 Therapeutic Antibody Fab Fragment (OKT3) (TAB-0416CL-F(E))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-Human CD3 Therapeutic Antibody scFv Fragment (OKT3) (TAB-0416CL-S(P))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Human Anti-Human CD3 Therapeutic Antibody scFv Fragment (TAB-0532CL-S(P))
-
- Type: Human antibody
Anti-Human EPCAM Therapeutic Antibody Fab Fragment (HE2) (TAB-0531CL-F(E))
-
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Chimeric Anti-Human CD3 Therapeutic Antibody Fab Fragment (TAB-0417CL-F(E))
-
- Type: Chimeric (mouse/human)
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Chimeric Anti-Human CD3 Therapeutic Antibody scFv Fragment (TAB-0417CL-S(P))
-
- Type: Chimeric (mouse/human)
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Human Anti-Human CD3 Therapeutic Antibody Fab Fragment (TAB-0532CL-F(E))
-
- Type: Human antibody
Humanized Anti-Human CD3 Therapeutic Antibody Fab Fragment (TAB-0418CL-F(E))
-
- Type: Humanized Antibody
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-Human CD3 Therapeutic Antibody scFv Fragment (TAB-0418CL-S(P))
-
- Type: Humanized Antibody
- Application: For in vitro and in vivo research use. Not intended for any applications in human.
Anti-EpCAM Antibody-Cytokine Fusion Protein, IgG (huKS)-IL2 (ACFP-SH036)
-
- Target: EpCAM
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Humanized from Mouse
- Cytokine 1 Species: Human
- Molecule Class: IgG1-IL2
Anti-EpCAM Antibody-Cytokine Fusion Protein, scIL12-IgG (KS)-IL2 (ACFP-SH150)
-
- Target: EpCAM
- Species Reactivity: Human
- Cytokine 1: IL2
- Host: Mouse
- Cytokine 1 Species: Human
- Molecule Class: scIL12-IgG1-IL2
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
© 2007 - 2020 Creative BioLabs All Rights Reserved